U.S. Markets close in 5 hrs 47 mins

Community Healthcare Trust Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

Community Healthcare Trust (NYSE:CHCT) Third Quarter 2022 Results

Key Financial Results

  • Revenue: US$24.8m (up 6.7% from 3Q 2021).

  • Funds from operations (FFO): US$13.8m (up 4.0% from 3Q 2021).

  • FFO margin: 55% (down from 57% in 3Q 2021). The decrease in margin was driven by higher expenses.

  • FFO per share: US$0.6 (up from US$0.58 in 3Q 2021).


All figures shown in the chart above are for the trailing 12 month (TTM) period

Community Healthcare Trust Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 16%.

Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the REITs industry in the US.

Performance of the American REITs industry.

The company's shares are up 2.0% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 2 warning signs for Community Healthcare Trust (1 shouldn't be ignored!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here